Y, Z., Z, M., X, S., M, Z., S, Z., X, F., & Z, A. (2026). Anticancer drug-induced interstitial lung disease: A critical appraisal of clinical practice guidelines and consensus statements. Expert opinion on drug safety, 25(6), 1093. https://doi.org/10.1080/14740338.2024.2315113
Παραπομπή σε μορφή Chicago (17η εκδ.)Y, Zhang, Ma Z, Sun X, Zhu M, Zhang S, Feng X, και An Z. "Anticancer Drug-induced Interstitial Lung Disease: A Critical Appraisal of Clinical Practice Guidelines and Consensus Statements." Expert Opinion on Drug Safety 25, no. 6 (2026): 1093. https://doi.org/10.1080/14740338.2024.2315113.
Παραπομπή σε μορφή MLA (9th εκδ.)Y, Zhang, et al. "Anticancer Drug-induced Interstitial Lung Disease: A Critical Appraisal of Clinical Practice Guidelines and Consensus Statements." Expert Opinion on Drug Safety, vol. 25, no. 6, 2026, p. 1093, https://doi.org/10.1080/14740338.2024.2315113.